Fig. 1From: The future outlook on allergen immunotherapy in children: 2018 and beyondMilestones in Allergen ImmunoTherapy’s history. AIT, Allergen ImmunoTherapy; EPIT, Epicutaneous ImmunoTherapy; FDA, Food and drug administration; IgE, immunoglobulin E; ILIT, Intralymphatic ImmunoTherapy; RDBPCT, Randomized, Double-Blind, Placebo-Controlled Trial; SCIT, Subcutaneous ImmunoTherapy; SLIT, Sublingual ImmunoTherapy; Th, T cells helper; VIT, Venom Allergen ImmunoTherapy; WAO, World Allergy Organization; WHO, World Health OrganizationBack to article page